1-Methyl-1H-indole-6-carboxylic acid

Catalog No.: 
ACTASO825
CAS No.: 
202745-73-1
Molecular Formula: 
C10H9NO2
Molecular Weight: 
175.19
1-Methyl-1H-indole-6-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$179.00In stockIn stock
25g95%$850.00In stockIn stock
100g95%$3298.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Methyl-1H-indole-6-carboxylic acid
IUPAC Name1-methyl-1H-indole-6-carboxylic acid
MDL No.MFCD08690250
Molecular FormulaC10H9NO2
Molecular Weight175.19
SMILESO=C(C1=CC2=C(C=C1)C=CN2C)O
InChI KeyDJQOGNYSBOIJKE-UHFFFAOYSA-N
Synonym1-Methyl-IH-indole-6-carboxylic acid | MFCD08690250 | CS-0135275 | AM807238 | AKOS005174480 | FT-0683821 | AB92307 | F2191-0007 | 1-methyl-1H-indole-6-carboxylicacid | 1-methyl-1H-indole-6-carboxylic acid, AldrichCPR | BB 0262283 | 1H-Indole-6-carboxylic
CAS No.202745-73-1
PubChem CID19819261

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H332-H315-H319-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACTASO825 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACUMYG185 route compound structure diagram
    ACUMYG1851204-32-6In Stock
  2. Then
  3. ACTASO825 route product structure diagram
    ACTASO825202745-73-1In Stock
Inquiry

2. ACTASO825 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBGUY914 route compound structure diagram
    ACBGUY91420996-87-6In Stock
  2. Then
  3. ACTASO825 route product structure diagram
    ACTASO825202745-73-1In Stock
Inquiry

3. ACTASO825 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYLXP485 route compound structure diagram
    ACYLXP485202745-74-2In Stock
  2. Then
  3. ACTASO825 route product structure diagram
    ACTASO825202745-73-1In Stock
Inquiry

Comments (0)